141 related articles for article (PubMed ID: 31101191)
1. Overexpression of miR-21 Is Associated With Recurrence in Patients With Hepatitis B Virus-Mediated Hepatocellular Carcinoma Undergoing Liver Transplantation.
Dundar HZ; Aksoy F; Aksoy SA; Tasar P; Ugras N; Tunca B; Egeli U; Cecener G; Yerci O; Kaya E
Transplant Proc; 2019 May; 51(4):1157-1161. PubMed ID: 31101191
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-224 Expression and Polymorphism Predict the Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma Patients After Liver Resection.
Wu C; Wang X; Zhang J; Tang G; Xu Y; Lu C; Li Y
Clin Lab; 2019 Jun; 65(6):. PubMed ID: 31232017
[TBL] [Abstract][Full Text] [Related]
3. Early-phase circulating miRNAs predict tumor recurrence and survival of hepatocellular carcinoma patients after liver transplantation.
Ng KT; Lo CM; Wong N; Li CX; Qi X; Liu XB; Geng W; Yeung OW; Ma YY; Chan SC; Man K
Oncotarget; 2016 Apr; 7(15):19824-39. PubMed ID: 26918346
[TBL] [Abstract][Full Text] [Related]
4. Hepatic miR-126 is a potential plasma biomarker for detection of hepatitis B virus infected hepatocellular carcinoma.
Ghosh A; Ghosh A; Datta S; Dasgupta D; Das S; Ray S; Gupta S; Datta S; Chowdhury A; Chatterjee R; Mohapatra SK; Banerjee S
Int J Cancer; 2016 Jun; 138(11):2732-44. PubMed ID: 26756996
[TBL] [Abstract][Full Text] [Related]
5. Lower expression of tumor microRNA-26a is associated with higher recurrence in patients with hepatocellular carcinoma undergoing surgical treatment.
Jones KR; Nabinger SC; Lee S; Sahu SS; Althouse S; Saxena R; Johnson MS; Chalasani N; Gawrieh S; Kota J
J Surg Oncol; 2018 Sep; 118(3):431-439. PubMed ID: 30076741
[TBL] [Abstract][Full Text] [Related]
6. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
Yen CS; Su ZR; Lee YP; Liu IT; Yen CJ
World J Gastroenterol; 2016 Jun; 22(22):5183-92. PubMed ID: 27298561
[TBL] [Abstract][Full Text] [Related]
7. Prognosis in liver transplantation recipients after hepatitis B virus recurrence.
Sun LY; Zhu ZJ; Qu W; Sun XY; Rao W; Liu Y
Hepatogastroenterology; 2014 Oct; 61(135):2047-51. PubMed ID: 25713909
[TBL] [Abstract][Full Text] [Related]
8. Liver transplantation in patients with hepatitis B virus-related hepatocellular carcinoma: the influence of viral characteristics on clinical outcome.
Wu TJ; Chan KM; Chou HS; Lee CF; Wu TH; Chen TC; Yeh CT; Lee WC
Ann Surg Oncol; 2013 Oct; 20(11):3582-90. PubMed ID: 23760589
[TBL] [Abstract][Full Text] [Related]
9. Liver transplantation for hepatitis B virus: Decreasing indication and changing trends.
Al-Hamoudi W; Elsiesy H; Bendahmash A; Al-Masri N; Ali S; Allam N; Al Sofayan M; Al Bahili H; Al Sebayel M; Broering D; Saab S; Abaalkhail F
World J Gastroenterol; 2015 Jul; 21(26):8140-7. PubMed ID: 26185387
[TBL] [Abstract][Full Text] [Related]
10. Relevance of microRNA-18a and microRNA-199a-5p to hepatocellular carcinoma recurrence after living donor liver transplantation.
Morita K; Shirabe K; Taketomi A; Soejima Y; Yoshizumi T; Uchiyama H; Ikegami T; Yamashita Y; Sugimachi K; Harimoto N; Itoh S; Ikeda T; Maehara Y
Liver Transpl; 2016 May; 22(5):665-76. PubMed ID: 26783726
[TBL] [Abstract][Full Text] [Related]
11. Decrease expression and clinicopathological significance of miR-148a with poor survival in hepatocellular carcinoma tissues.
Ajdarkosh H; Dadpay M; Yahaghi E; Pirzaman ER; Fayyaz AF; Darian EK; Mokarizadeh A
Diagn Pathol; 2015 Aug; 10():135. PubMed ID: 26248880
[TBL] [Abstract][Full Text] [Related]
12. Predictive value of expression and promoter hypermethylation of XAF1 in hepatitis B virus-associated hepatocellular carcinoma treated with transplantation.
Zhang F; Wu LM; Zhou L; Chen QX; Xie HY; Feng XW; Zheng SS
Ann Surg Oncol; 2008 Dec; 15(12):3494-502. PubMed ID: 18830757
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of microRNA-155 promotes cancer cell invasion and predicts poor survival of hepatocellular carcinoma following liver transplantation.
Han ZB; Chen HY; Fan JW; Wu JY; Tang HM; Peng ZH
J Cancer Res Clin Oncol; 2012 Jan; 138(1):153-61. PubMed ID: 22071603
[TBL] [Abstract][Full Text] [Related]
14. Identification of recurrence-related microRNAs in hepatocellular carcinoma following liver transplantation.
Han ZB; Zhong L; Teng MJ; Fan JW; Tang HM; Wu JY; Chen HY; Wang ZW; Qiu GQ; Peng ZH
Mol Oncol; 2012 Aug; 6(4):445-57. PubMed ID: 22552153
[TBL] [Abstract][Full Text] [Related]
15. Donor miR-196a-2 polymorphism is associated with hepatocellular carcinoma recurrence after liver transplantation in a Han Chinese population.
Xu X; Ling Q; Wang J; Xie H; Wei X; Lu D; Hu Q; Zhang X; Wu L; Zhou L; Zheng S
Int J Cancer; 2016 Feb; 138(3):620-9. PubMed ID: 26365437
[TBL] [Abstract][Full Text] [Related]
16. Loss of tumor suppressor miR-126 contributes to the development of hepatitis B virus-related hepatocellular carcinoma metastasis through the upregulation of ADAM9.
Xiang LY; Ou HH; Liu XC; Chen ZJ; Li XH; Huang Y; Yang DH
Tumour Biol; 2017 Jun; 39(6):1010428317709128. PubMed ID: 28639884
[TBL] [Abstract][Full Text] [Related]
17. miR-203 expression predicts outcome after liver transplantation for hepatocellular carcinoma in cirrhotic liver.
Chen HY; Han ZB; Fan JW; Xia J; Wu JY; Qiu GQ; Tang HM; Peng ZH
Med Oncol; 2012 Sep; 29(3):1859-65. PubMed ID: 21786180
[TBL] [Abstract][Full Text] [Related]
18. Differential impact of risk factors for tumor recurrence in hepatitis B and hepatitis C virus-infected patients undergoing liver transplantation for hepatocellular carcinoma.
Krasnodębski M; Grąt M; Masior Ł; Patkowski W; Krawczyk M
Ann Transplant; 2015 Feb; 20():70-5. PubMed ID: 25639825
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-29a-5p is a novel predictor for early recurrence of hepatitis B virus-related hepatocellular carcinoma after surgical resection.
Zhu HT; Dong QZ; Sheng YY; Wei JW; Wang G; Zhou HJ; Ren N; Jia HL; Ye QH; Qin LX
PLoS One; 2012; 7(12):e52393. PubMed ID: 23285022
[TBL] [Abstract][Full Text] [Related]
20. [The relationship between hepatocellular carcinoma recurrence and hepatitis B virus recurrence after liver transplantation].
Li MR; Yi SH; Cai CJ; Yi HM; An YL; Wei M; Chen GH
Zhonghua Gan Zang Bing Za Zhi; 2011 Apr; 19(4):271-4. PubMed ID: 21586225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]